Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT05563857 Active, not recruiting - Depression Clinical Trials

Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions

Start date: October 19, 2022
Phase: N/A
Study type: Interventional

US residents who have gastrointestinal issues sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will NOT utilize clinical sites.

NCT ID: NCT05561933 Active, not recruiting - Depression Clinical Trials

Scaling Well-Being for Educators During COVID-19

Start date: October 21, 2022
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial (RCT) of the four-week Healthy Minds Program (HMP) app Foundations training in employees of Jefferson County Public Schools (JCPS) in Louisville, KY. The study will enroll 1300 JCPS employees. After completing the baseline assessment, participants will be randomly assigned to the intervention (i.e., the Healthy Minds Program App) or to a "Choice" control condition. HMP assigned participants will receive instructions and support in downloading and activating the app. Choice assigned participants will receive a list of resources that are focused on the science of well-being and happiness consisting of TED talk videos and books. 10 copies of each suggested book will be available for participants to check out. TED talk video links will be provided and are free to watch. Each week during the 4-week intervention period, participants in both conditions will complete the same weekly set of measures. Within two-weeks following the end of the intervention period, all participants will complete the post-test assessment. Approximately five to six months following post-test, participants will complete the follow-up assessment. In addition to study team collected data, the research team will receive from the district multiple years of student records (e.g., standardized assessments, attendance, disciplinary referrals) linked to teachers (teachers only, not other categories of employees who choose to participate). The researchers predict that participants assigned to the intervention will demonstrate significantly reduced anxiety and depressive symptoms and significantly improved well-being after the intervention, and these improvements will persist at the follow-up (primary outcomes). It is hypothesized that baseline participant characteristics and early experience of the intervention will predict treatment adherence, study drop-out and outcomes, and that treatment engagement will moderate outcomes. In addition, the investigators predict that intervention period improvements on well-being skills assessed weekly will mediate long-term improvements on primary outcomes.

NCT ID: NCT05551702 Active, not recruiting - Moderate Depression Clinical Trials

Treating Depression With Text Messaging

Start date: July 6, 2022
Phase: N/A
Study type: Interventional

The purpose of the research study is to investigate whether CBT-txt, a counseling program delivered by text messages is effective in stopping or reducing depressive symptoms. CBT-txt is based on a counseling program that has been proven to reduce depression when delivered in-person and on the web, but has not yet been tested or shown to be effective when delivered by text.

NCT ID: NCT05531591 Active, not recruiting - Depression Clinical Trials

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

ONR
Start date: August 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD), and to test whether treatment-resistant late life depression is associated with declines in memory and attention and brain structure and function.

NCT ID: NCT05525689 Active, not recruiting - Depression Clinical Trials

Evaluating Technology Enabled Services in Perinatal Depression

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.

NCT ID: NCT05488782 Active, not recruiting - Depression Clinical Trials

TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension

TEAM-Red
Start date: January 30, 2023
Phase: N/A
Study type: Interventional

The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=25) vs. enhanced wait-list (eWL, N=25) control in depressed young (<50 years) African-American (AA) women at risk for hypertension.

NCT ID: NCT05477758 Active, not recruiting - Depression Clinical Trials

The Impact of Pain on Depression Outcomes

Start date: September 15, 2022
Phase:
Study type: Observational

This study is a secondary data analysis of three of largest Randomised Controlled Trials (RCTs) of behavioural activation (BA) for older people with depression in the United Kingdom (UK) primary care. The analysis will aim to explore the impact of pain on depression outcomes of older people receiving BA and potentially identify sub-groups of people who may not respond as well to treatment.

NCT ID: NCT05477706 Active, not recruiting - Depression Clinical Trials

Peer Intervention to Improve Access Among Rural Women Veterans With Psychological Distress and Unmet Social Needs

EMBER
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This research project will refine and evaluate delivery of a peer-delivered evidence-based intervention to improve perceived access and actual engagement with mental health treatment and social resource service use among rural women Veterans, especially Veterans of color, with psychological distress and unmet social needs.

NCT ID: NCT05439603 Active, not recruiting - Clinical trials for Major Depressive Disorder

ANC-501 in the Treatment of Adults With Major Depressive Disorder

Start date: September 19, 2022
Phase: Phase 2
Study type: Interventional

This is a single-arm, open-label Phase 2 study to assess the safety, tolerability, pharmacokinetics (PK), and activity of ANC-501 oral capsules as adjunctive treatment in subjects diagnosed with major depressive disorder (MDD)

NCT ID: NCT05436145 Active, not recruiting - Depression Clinical Trials

Intern Health Study 2022 and 2023

IHS
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The aim of this trial is to evaluate the efficacy of an intervention (delivered through a smartphone) for improving the mood, physical activity, and sleep of medical interns.